The existence of a new Αρα LI restriction fragment length polymorphism in the third intron of the low density lipoprotein (LDL) receptor gene was described. As a gene probe we used a newly constructed derivative of pLDLR 3 which did not contain the highly repetitive Alu-sequences in exon 18. This new gene probe detected all exon sequences containing restriction fragments, and enabled us to demonstrate all described polymorphisms, which might be useful for genetic linkage studies. Based on analysis of 72 unrelated normoand hypercholesterolaemic persons, the frequency of the allele A2, which showed the additional cutting site, was determined to be 0.05. With the simplified gene probe, pLDLR Δ, we also studied other polymorphisms. A clear linkage disequilibrium between the Pvu II and Msp I polymorphisms was detected. This, and the previously described linkage disequilibrium of the two Msp I polymorphisms, demonstrate that the LDL receptor gene is apparently less heterogeneous than expected from the number of described polymorphisms.
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Recently, the full-length cDNA of the LDL receptor gene has been cloned (4), and a variety of mutations in this gene have been found among patients with familial hypercholesterolaemia (2, 5 -9) . These experiments were usually carried out by hybridizing genomic DNA or cytoplasmic m-RNA with the cDNA to survey both genomic gerie organisation and m-RNA expression. Since highly repetitive Alu sequences were present at the 3' end of the cDNA, direct hybridization experiments using the full-length cDNA clone were impossible. Therefore fragments of the cDNA, which detect only some of the 18 exons, were employed for hybridization (9, 10) . The most frequently used gene probe was the Bam HI fragment which contained complementary sequences of exon 10 to 18. For this reason, most of the detected polymorphisms have been localized in the 3' region of the gene. In the present work, we prepared a cDNA probe from pLDLR 3 which can detect all exon-containing restriction fragments of the LDL receptor gene without further probe processing.
To date, 11 restriction fragment length polymorphisms have been described in the LDL receptor gene (10) (11) (12) (13) (14) (15) (16) (17) (18) . For the diagnosis of familial hypercholesterolaemia, the polymorphisms are used to detect alleles which correlated with the disease in pedigree analysis (19) . The identification of the new Αρα LI polymorphism, which was localized in the 5' region of the gene, provided additional information for genetic analysis.
Materials and Methods
Preparation of the gene probe pLDLR Δ
The full-length cDNA clone pLDLR 3 was obtained from the American Type Culture Collection (Rockville, Md., USA, ATCC-Nr. 57005). Cloned pLDLR 3 was cleaved with Bsp M2 (Biolabs, Beverly, MA, USA), which cuts at nucleotide position 4580 of the cDNA. The linear molecule was then partially digested with Dra III (Biolabs), which cleaves at positions 3115 and 3626. The resulting fragments were separated by preparative agarose gel electrophoresis (6 g/1, Type Ha, Sigma, Deisenhofen, FRG), and the ~~ 7 χ ΙΟ 3 base pairs fragment was eluted. After Klenow fragment treatment (Boehringer Mannheim, FRG) to prepare blunt ends, the fragment was recircularized with T4 DNA ligase (BRL, Eggenstein, FRG). E. coli cells, strain HB 101, were made competent by the method of Hanahan and transformed with the ligation products (20) . One clone, which showed the expected cleavage patterns with Dra III, Hae III, Rsa I or Msp I was selected and was designated pLDLRA. Plasmid DNA was prepared by the Triton X-100 lysis method and purified by CsCl gradient centrifugation (21) . Purified DNA fragments were radiolabeled by an oligonucleotide priming kit (Amersham, Braunschweig, FRG). The unincorporated nucleotides were separated on a Sephadex G-50 column (Pharmacia, Freiburg, FRG). The specific activity of the probes was greater than 5 χ 10 8 counts/min χ μg.
DNA isolation
Blood samples were collected in EDTA Monovettes (Sarstedt, Numbrecht, FRG) and frozen at -70 °C. DNA was prepared from leukocytes by the Triton X-100 lysis method (22) . 
DNA digestion and

Hybridization
The conditions for hybridization have been previously described (23) . The posthybridization washes consisted of three 10 min washes at room temperature in a solution of 2 χ SSC(1 χ SSC = NaCl, 0.15 moi/1, sodium citrate, 15 mmol/1) and SDS, 1 g/1, and three 15 min washes at 56 °C in a solution of 0,1 χ SSC and SDS, 1 g/1. The nitrocellulose filters were then exposed to X-ray films (XAR, Kodak, USA) for 1-4 days at -70 °C.
Collective
Patients with familial hypercholesterolaemia (48 individuals), type Ha, were followed up in the outpatient clinic of our department. These patients had a family history of hypercholesterolaemia and in some cases of myocardial infarctions and tendon xanthomata. The LDL-cholesterol ranged between 180 and 240 mg/dl = 4.7 and 6.2 inmol/1 during a cholesterollowering diet and treatment with one or more lipid-lowering drugs. Normolipidaemic subjects (24 individuals) were laboratory personnel and medical students.
Results
Improved LDL receptor gene probe
As expected for hybridization probes which carried Alu repeats, hybridization experiments were impossible with pLDLR 3. Using two restriction sites in close proximity to the Alu repeats (nucleotide position 3717 and 4478, fig. 1 ) these sequences were deleted in pLDLR 3. The resulting clone was named pLDLR Δ (for details see Materials and Methods). In the analytical restriction experiments, we took into account the modification in the promoter region of pLDLR 3 as mentioned by the American Type Culture Collection. With pLDLR Δ all exon sequences containing restriction fragments could be detected. An example of a genomic Southern blot is shown in figure 2 . New Αρα LI polymorphism DNA from normolipidaemic individuals or from patients with familial hypercholesterolaernia was assayed for the two Αρα Li polymorphisms previously described (15) . Double cleavage with Αρα LI and Bam HI improved the differentiation of fragments (15) . The gene probes used contained sequences from exons 16 to 18. After hybridization with the pLDLR Δ gene probe, which detects 3' and also 5' sequences, a third polymorphic Αρα LI site became obvious ( fig. 2) . Two additional fragments with sizes of about 4.8 and 7.2 χ 10 3 base pairs were detectable in some subjects. We designated the allele with the additional cutting site A2, and the allele without this site Al. By double cleavage with Αρα LI and Kpn I, Eco RI or Bam HI the additional Αρα LI site in allele A2 was located in intron 3. With the 268 base pairs Pvu II fragment from pLDLRA, which detects exons 3 and 4, this polymorphism could be selectively visualized (right panel fig. 2 ).
The allele frequencies of the new Αρα LI polymorphism were determined in our collective of 72 unrelated individuals. For all investigated persons the frequencies of allele Al and allele A2 are 0.95 and 0.05, respectively. The normolipidaemic population (24 individuals) showed in 23 cases the genotype A1A1, and in one case the genotype AI A2. In the population of independent patients with familial hypercholesterolaemia (48 individuals), the genotype AI AI was present in 43 cases, A1A2 in 4 cases, and A2A2 in one case.
Mendelian inheritance of the newly discovered polymorphism was demonstrated in three families. One example is shown in figure 3 . In this family the allele A2 was found to be associated with familial hypercholesterolaemia. Linkage disequilibrium between polymorphisms Including the new Αρα LI polymorphism, 12 restriction fragment length polymorphisms were described in the LDL receptor gene. Three polymorphisms were detected for Αρα LI, and two for Msp I. In our studies we considered the Msp I polymorphism which is located in exon 18 and the Αρα LI polymorphism in intron 15. The allele frequencies of these and of the Pvu II and Pst I polymorphisms were determined in our collective. Following a proposal of the Committee on Human Gene Mapping by Recombinant DNA Techniques, the alleles have been designated Al and A2 according to decreased allelic frequencies (24) . A comparison of the homozygous Pvu II genotypes Al Al and A2A2 with the corresponding Msp I genotypes of the same patients revealed a striking linkage disequilibrium between the Pvu II and the Msp I polymorphisms (tab. 1). In 57 out of 61 cases, the Pvu II genotypes A1A1 and A2A2 were associated to the corresponding Msp I alleles (χ 2 = 14.92, f = 1, ρ < 0.001). A similar relationship between the genotypes of other restriction enzymes studied was not found.
Discussion
In order to obtain a gene probe which facilitated detection of all exons in the LDL receptor gene, we deleted the Alu sequences in pLDLR 3. These sequences were located in exon 18 and were involved in some rearrangements detected in patients with familial hypercholesterolaemia (5, 25) . Alu repeats occur about 300000 times in the human genome (26) .
All of these repeats hybridized in genomic Southern blot experiments when the pLDLR 3 probe was used. With the newly constructed plasmid pLDLR Δ, a gene probe was available to study all exon-containing restriction fragments of the LDL receptor gene in one experiment. All restriction fragment length polymorphisms described so far were detectable with this gene probe, which has thus proved of great practical importance for genetic linkage studies in families with inherited hypercholesterolaemia. A third Αρα LI polymorphism in the LDL receptor gene ha$ emerged by screening with the gene probe pLDLRA. The results of mapping experiments using an exon 3-and 4-specific fragment for hybridization showed the polymorphic site to reside in intron 3. The new polymorphic Αρα LI site is located closer to the 5' end than any of the other described polymorphisms (fig.  2 ). The frequency of the rare allele A2 is 0.05 in all studied persons. In the population of patients with familial hypercholesterolaemia the A2 allele occurred at a higher frequency than in normolipidaemic persons. Whether or not a linkage disequilibrium of allele Al and allele A2 exists between the two populations can only be clarified by the investigation of a larger number of persons. Pedigree analysis to determine whether an association exists between the A2 allele and familial hypercholesterolaemia, as in the analysis shown in figure 3 , is in progress.
The three Αρα LI polymorphisms together with the 9 other described polymorphisms permit the identification of a large number of different alleles. However, the actual number of different alleles observed is smaller than the theoretically possible number. The LDL receptor gene seems to be less heterogeneous than expected from the number of polymorphisms. Here we report the linkage disequilibrium between the Pvu II and Msp I genotypes. The linkage disequilibrium of the two Msp I polymorphisms was published previously; as a result two haplotypes can now be characterized. In haplotype 1, the Pvu II site is absent at the polymorphic position, and the two additional Msp I sites are present. In haplotype 2, the additional Pvu II site is present, and the two Msp I sites are absent.
Since the number of heterozygous individuals for the Pstl and Αρα LI polymorphisms was very large, correlations with other polymorphisms were not possible (tab. 1). In such cases haplotypes can only be established by family analysis. In phenylketonuria, it was shown that polymorphism-defined haplotypes were associated with the disease (27) . In South Africa, such an association was described for familial hypercholesterolaemia (28) . This finding and a frequently detected mutation in specific ethnic groups, causing familial hypercholesterolaemia, can presumably be interpreted as a founder gene effect (29, 30) . Whether it will be possible to detect distinct haplotypes, which frequently appear in patients with familial hypercholesterolaemia, in a central European population, remains to be elucidated in the future by pedigree analysis.
